Home/ Stocks/ LSTA

Lisata Therapeutics, Inc. Common Stock

LSTA XNAS

$3.15 -0.08 (-2.48%) ▼ 15-min delayed

Open

$3.20

High

$3.21

Low

$3.15

Volume

19.8K

Market Cap

$28.69M

About Lisata Therapeutics, Inc. Common Stock

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The company has one operating segment, the research and development of its investigational drug product.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 21 Website →

Key Financials

Period	Revenue	Net Income	EPS
TTM 2025	$170.0K	$-16,586,000	$-1.91
FY 2025	$170.0K	$-16,586,000	$-1.91
Q3 2025	$0	$-4,249,000	$-0.49
Q2 2025	$70.0K	$-4,659,000	$-0.54

Earnings & Analyst Ratings

Next Earnings: Wed, Aug 5, 2026

Calendar →

Related Market News

No specific coverage for LSTA yet. Check out our latest market news or earnings calendar.

Get LSTA Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Lisata Therapeutics, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.